Presentation is loading. Please wait.

Presentation is loading. Please wait.

Innovations :Curing the Incurable. Disease Burden: Key disease conditions DiseasePrevalence :2005Prevalence (E): 2015 Cardiovascular36 Million62 Million.

Similar presentations


Presentation on theme: "Innovations :Curing the Incurable. Disease Burden: Key disease conditions DiseasePrevalence :2005Prevalence (E): 2015 Cardiovascular36 Million62 Million."— Presentation transcript:

1 Innovations :Curing the Incurable

2 Disease Burden: Key disease conditions DiseasePrevalence :2005Prevalence (E): 2015 Cardiovascular36 Million62 Million Diabetes31 Million46 Million Blindness

3 Healthcare Challenge Rising inequities In healthcare Huge Population Skewed Health Infrastructure Poor affordability Increasing Disease Incidence & prevalence Lack of awareness Increasing Treatment costs

4 The way ahead: Innovation Innovation Process innovation Technology innovation Business Model innovation

5 Why Innovation Today, 21st century medical technology is often delivered with 19th century organization structures, management practices, and pricing models -Michael Porter

6 Process Innovation: Aravind Hospital Aravind Hospital: 2,00,000+ people treated every year 60% of operations free of cost Average cost of surgery : 25US$ Average duration of surgery: 10 minutes Infection rate : 4/10,000 operations

7 Process Innovation: Aravind Eye Hospital Process Innovation StandardizationReproducibilityScale

8 Technology Innovation: Shantha Biotech Shantha Biotech: 1 st company to produce indigenous Hepatitis B Vaccine Resulting in a 30 times reduction in price of Hepatitis B Vaccine 1 st company to launch a 4 in 1 vaccine A strong pipeline of biotech drugs Major supplier of Hepatitis-B vaccines to United States Got acquired by Merieux Alliance's subsidiary ShanH in 2006

9 Technology Innovation: Shantha Biotech Technology Innovation Collaborative Public Private R&D Productive International Technology collaboration State of the art Manufacturing facilities

10 Business Model Innovation: Mankind Pharma Mankind Pharma: A compound annual growth rate of 35% over last 4 years Ranked as 9 th largest Pharma company in India Majority of sales coming from mature brands in slow growth segments Initial success came from rural areas and smaller towns Largest sales force :5000 Medical representatives Mankind presence in every village having inhabitants

11 Business Model Innovation: Mankind Pharma Business Model Innovation Focus on rural areas & Tier 2 &3 towns Low fixed cost, Aggressive pricing Right product mix Strong sales force Huge distribution network Easy availability

12 Innovation : What will it lead to……….. New Products Lowering of Cost/ price Ensure wider availability Technology Innovation Process Innovation Business Model Innovation

13 Thank You


Download ppt "Innovations :Curing the Incurable. Disease Burden: Key disease conditions DiseasePrevalence :2005Prevalence (E): 2015 Cardiovascular36 Million62 Million."

Similar presentations


Ads by Google